Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02506543 · ClinicalTrials.gov registry record · NA
Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia
A NA study of Domestic Violence and Sexual Assault, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 1,014
- Enrollment target
- 2
- Study locations
NCT02506543 is a NA study of Domestic Violence and Sexual Assault that has completed, run by Columbia University. The registered enrollment target is 1,014 participants, above the 384-participant average among 12 other Domestic Violence trials with a reported enrollment target (164% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT02506543, a NA study of Domestic Violence and Sexual Assault, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,014 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study is a randomized controlled trial of COMPASS, an intervention for adolescent girls in three refugee camps in Ethiopia. The study design will employ a two group wait-list cluster randomized controlled trial where girls will be invited to participate in the COMPASS program, assigned to groups of approximately 20 for the purposes of the program, complete a pre-test baseline assessment, and will then be randomized by group to the intervention or control condition. In addition, qualitative research will address additional questions of acceptability, processes of change and best practice. Groups in three refugee camps - Sherkole, Bambasi, and Tongo - will be randomized to determine whether the participants receive the intervention or are placed on the wait-list immediately following the baseline. Those that do not get the curriculum during the study will receive it following the endline phase of the study so as to not create tensions or jealousies. The intervention, the COMPASS program, will involve a structured intervention for girls between the ages of 13-19 that is intended to engage adolescent girls, those who are influential in their lives, service providers and other stakeholders, with the ultimate goal of co-creating environments in which girls are valued and safe. The program is centered on establishing or supporting community-supported safe spaces for girls where they can come and gather among themselves and participate in a structured life-skills curriculum.
Conditions Studied
Interventions
- BEHAVIORAL COMPASS
- BEHAVIORAL No intervention
Study Locations (2)
New York
- Columbia University - New York
Other
- International Rescue Committee - Addis Ababa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,014 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02506543
The ClinicalTrials.gov registry entry for NCT02506543 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,014 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 384-participant average among 12 other Domestic Violence trials with a reported enrollment target (164% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Domestic Violence appearing as the primary indexed condition, and to 2 interventions - of which COMPASS is the first listed.
NCT02506543 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Other.
Frequently Asked Questions
What is clinical trial NCT02506543 about?
NCT02506543 is a clinical study titled "Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia". The study is a randomized controlled trial of COMPASS, an intervention for adolescent girls in three refugee camps in Ethiopia. The study design will employ a two group wait-list cluster randomized controlled trial where girls will be invited to participate in the COMPASS program, assigned to groups...
What is the current status of trial NCT02506543?
This trial is currently completed. It is a NA study. The enrollment target is 1,014 participants. The study started on 2015-08. Estimated completion is 2016-09.
What conditions does trial NCT02506543 study?
This clinical trial studies the following conditions: Domestic Violence, Sexual Assault, Interpersonal Relations, Marital Status.
What interventions are being tested in trial NCT02506543?
The interventions under investigation include: COMPASS (BEHAVIORAL), No intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02506543?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02506543 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Domestic Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial to Reduce Perinatal Intimate Partner Violence
RECRUITING · NA
-
Occupational Therapy for Adults Who Have Experienced Intimate Partner Violence (IPV)
RECRUITING · NA
-
Single Session Intervention to Promote Hope
RECRUITING · NA
-
Safety and Effectiveness of Computer Screening for Intimate Partner Violence
COMPLETED · NA
-
Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women
COMPLETED · NA
-
Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.